FindTrial
Sign In

A Comparative Study Of Analgesic Effect Of Intrathecal Nalbuphine And Fentanyl As An Adjuvant In Lower Abdomen And Lower Limb Surgery.

A Comparative Study Of Analgesic Effect Of Intrathecal Nalbuphine And Fentanyl As An Adjuvant In Lower Abdomen And Lower Limb Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037720
Enrollment
100
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S978- Crushing injury of foot Health Condition 2: S880- Traumatic amputation at knee level Health Condition 3: S880- Traumatic amputation at knee level

Interventions

Control Intervention1: Fentanyl: Fentanyl 25 micrograms will be administered with 12.5 mg of 0.5% hyperbaric buivacaine in subarachnoid blockade Control Intervention2: Nalbuphine: Nalbuphine 0.8 mg wi

Sponsors

IMS BHU VARANASI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between18-65 years,height between160+-10cm,weight between50-75kg,ASA I and II Status,expected to take time of 120-150 minutes

Exclusion criteria

Exclusion criteria: Patient refusal,patient on beta blocker therapy,ASA III and IV,Patient with known to hypersensitivity to any of the study drugs,pregnancy and patient on sedatives and tranquilizer.

Design outcomes

Primary

MeasureTime frame
Level of sensory block and pain reliefTimepoint: 5 ,15,30,60,120,360,1440 minutes—

Secondary

MeasureTime frame
Full recovery of sensory blockTimepoint: Hours 6 and 12—

Countries

India

Contacts

Public ContactDRRAJEEV KUMAR DUBEY

Institute of medical science BHU Varanasi Uttar Pradesh India

rajeevdubeyrk@gmail.com9839927283

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026